首页> 外文会议>Russian-German Forum on Nanotechnology >The Influence Of The Peptide Molar Ratios On The Functionalization Of Gold Nanoparticles
【24h】

The Influence Of The Peptide Molar Ratios On The Functionalization Of Gold Nanoparticles

机译:肽摩尔比对金纳米粒子官能化的影响

获取原文

摘要

Au nanoparticles (NPs) functionalized with L-cysteine (Cys) and cysteine-glycine (Cys-Gly) were synthetized. The AuNPs were prepared using sodium citrate as reducing agent. The influence of the molar concentrations of Cys and Cys-Gly, as well as the sodium citrate is studied on particle size and particle size distribution. TEM measurements revealed the formation of AuNPs with diameter in the range 5-35 nm which corresponds to nontoxic sizes [we should add a reference here, perhaps number one]. The optimal particle size for biomedical application along with narrow particle size distribution was observed for samples prepared with molar ratio of C_(Au):C_(citrate) =1:10. The results of UV-Vis spectroscopy revealed the interaction of the AuNPs with Cys and Gly-Cys demonstrated by a visible change in the absorption intensities of the plasmon peak located at 520 nm after AuNP functionalization and a slight shifting of this gold nanoparticles plasmon peak. Thus, any dielectric shell on surface of particles with more refraction index (and, correspondingly, dielectric function) can produce the particles with the red shift. Such effect of the surface shell with red-shift in the range of few nanometers observed for the AuNPs functionalized with Cys and Cys-Gly (Fig. 4) can be interpreted as thin or discontinuous layer of aminoacid molecules according to the data of optical spectra simulation. The optimum concentration of precursors was found for the suitable nontoxic AuNPs according to two main criteria. Firstly, particle size suitable to overcome blood brain barrier without being toxic (~20 nm) and nontoxic spherical shape. AuNPs obtained using 10μM of citrate demonstrated the optimum narrow particle size distribution with 20 nm colloids preferentially formed. After particles functionalization with the aminoacid and peptide the particle size distribution did not change significantly. However, the number of particles with the size of 20 nm increases more than (add %) compare to the citrate method.
机译:用L-半胱氨酸(Cys)和半胱氨酸 - 甘氨酸(Cys-Gly)官能化的Au纳米颗粒(NPS)被合成。使用柠檬酸钠作为还原剂制备AUNP。研究了Cys和Cys-Gly的摩尔浓度以及柠檬酸钠的影响,对粒度和粒度分布进行了研究。 TEM测量揭示了在5-35nm范围内形成的肛周,其对应于无毒尺寸[我们应该在此添加参考,也许是数字。对于用C_(Au)的摩尔比制备的样品,观察到生物医学应用以及较窄的粒度分布的最佳粒径以及摩尔比的样品:C_(柠檬酸盐)= 1:10。 UV-Vis光谱的结果揭示了AuNP与Cys和Gly-Cys的相互作用,通过在AUNP官能化后位于520nm的等离子体峰的吸收强度的可见变化,并逐渐变化该金纳米粒子等离子体峰值。因此,具有更多折射率(和相应的介电功能)的颗粒表面上的任何介电壳可以产生具有红色偏移的颗粒。对于用Cys和Cys-Gly(图4)官能化的AuNP的剖腹壳在几纳米范围内的这种效果可以根据光谱的数据解释为薄或不连续的氨基酸分子层模拟。根据两个主要标准,对合适的无毒性AUNPS发现了前体的最佳浓度。首先,粒度适于克服血脑屏障而不具有毒性(〜20nm)和无毒球形。使用10μm柠檬酸盐获得的AuNP证明了优先形成20nM胶体的最佳窄粒度分布。在用氨基酸和肽官能化官能化之后,粒度分布不会显着变化。然而,尺寸为20nm的粒子的数量比(加%)与柠檬酸盐法相比增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号